Crescendo Biologics Ltd.

Crescendo Biologics Ltd.

Crescendo Biologics Ltd.

Date Founded



Meditrina Building 260,Babraham Research Campus,Cambridge, Cambridgeshire CB22 3AT

Type of Company


Employees (Worldwide)

51 - 100


Other Business & Consulting Services
Hospitals & Patient Services
Holding Companies

Company Description

Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm’s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom.

Contact Data
Trying to get in touch with decision makers at Crescendo Biologics Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Senior Director of Research

Finance Director

Associate Director of BD & IP

Senior Vice President, Research

Board of Directors

Clinical & Scientific Advisory Group at Capella Bioscience Ltd.

Partner, Life Sciences at Andera Partners SCA

Partner, Life Sciences at IP Group Plc

Chief Medical Officer & Global Head Research & Development at Hookipa Pharma, Inc.

Chief Executive Officer at Crescendo Biologics Ltd.

Director at Targovax ASA

Managing Partner at Sofinnova Partners SAS

Founder at BioHorizons, Inc.

Paths to Crescendo Biologics Ltd.
Potential Connections via
Relationship Science
Crescendo Biologics Ltd.
Advisors & Consultants
Scientific Advisor

Founding Scientist at PsiOxus Therapeutics Ltd.

Scientific Advisor

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Details Hidden

IP Group invests in companies located in UK, US and Australasia. The firm focuses on various life sciences and technology sectors. It provides financing for early stage capital requirements.

Details Hidden

Takeda Ventures invests in companies located in US, Canada and Europe. The firm targets targets companies operating in the fields of health technology and health services. They provide financing for seed stage and early stage transactions.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Crescendo Biologics Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Crescendo Biologics Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Crescendo Biologics Ltd..